Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-25T13:08:48.863Z Has data issue: false hasContentIssue false
  • English
  • Français

Genotoxicity Study on Nicotine and Nicotine-Derived Nitrosamine by Accelerator Mass Spectrometry

Published online by Cambridge University Press:  18 July 2016

X. S. Li ,
H. F. Wang ,
J. Y. Shi ,
X. Y. Wang ,
Y. F. Liu ,
K. Li ,
X. Y. Lu ,
J. J. Wang ,
K. X. Liu  and
Z. Y. Guo
X. S. Li
Affiliation:
Department of Technical Physics, Peking University, Beijing 100871, China
H. F. Wang
Affiliation:
Department of Technical Physics, Peking University, Beijing 100871, China
J. Y. Shi
Affiliation:
Department of Technical Physics, Peking University, Beijing 100871, China
X. Y. Wang
Affiliation:
Department of Technical Physics, Peking University, Beijing 100871, China
Y. F. Liu
Affiliation:
Department of Technical Physics, Peking University, Beijing 100871, China
K. Li
Affiliation:
Institute of Heavy Ion Physics, Peking University, Beijing 100871, China
X. Y. Lu
Affiliation:
Institute of Heavy Ion Physics, Peking University, Beijing 100871, China
J. J. Wang
Affiliation:
Institute of Heavy Ion Physics, Peking University, Beijing 100871, China
K. X. Liu
Affiliation:
Institute of Heavy Ion Physics, Peking University, Beijing 100871, China
Z. Y. Guo
Affiliation:
Institute of Heavy Ion Physics, Peking University, Beijing 100871, China
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We have studied DNA adduction with 14C-labeled nicotine and nicotine-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), by accelerator mass spectrometry (AMS) in mouse liver at doses equivalent to low-level exposure of humans. The dose ranges of nicotine and NNK administered were from 0.4 μg to 4.0×102 μg kg b.w.-1, and from 0.1 μg to 2.0×104 μg kg b.w.-1, respectively. In the exposure of mice to either nicotine or NNK, the number of DNA adducts increased linearly with increasing dose. The detection limit of DNA adducts was 1 adduct per 1011 nucleotide molecules. This limit is 1–4 orders of magnitude lower than that of other techniques used for quantification of DNA adducts. The results of our animal experiments enabled us to speculate that nicotine is a potential carcinogen. According to the procedure for 14C-labeled-NNK synthesis, we discuss the ultimate chemical speciation of NNK bound to DNA. From the animal tests we derived a directly perceivable relation between tobacco consumption and DNA adduction as the carcinogenic risk assessment.

Type
Other Articles
Information
Radiocarbon , Volume 38 , Issue 2 , 1996 , pp. 347 - 353
Copyright
Copyright © The American Journal of Science 

References

Adams, J. D., O'Mara-Adams, K. J. and Hoffmann, D. 1987 Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes. Carcinogenesis 8(5): 729–731.Google Scholar
Beland, F. A. and Poirier, M. C. 1993 Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment. Environmental Health Perspectives 99: 5–10.Google Scholar
Belinsky, S. A., Foley, J. F., White, C. M., Anderson, M. W. and Maronpot, R. R. 1990 Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Research 50: 3772–3780.Google Scholar
Brunnemann, K. D., Scott, J. C. and Hoffmann, D. 1982 N-nitrosomorpholine and other volatile N-nitrosamines in snuff tobacco. Carcinogenesis 3: 693–696.Google Scholar
Chen, C. E., Guo, Z. Y., Yan, S. Q. and Zhang, Z. F. 1990 Status of the tandem accelerator mass spectrometry facility at Peking University. Nuclear Instruments and Methods in Physics Research B52: 306–309.CrossRefGoogle Scholar
Creek, M. R., Frants, C. E., Fulta, F., Haack, K., Redwine, K., Shen, N., Turteltaub, K. W. and Vogel, J. S. 1994 14C AMS quantification of biomolecular interactions using microbore and plate separations. Nuclear Instruments and Methods in Physics Research B92: 454–458.CrossRefGoogle Scholar
Decker, K. and Sammeck, R. 1964 Radiochemical synthesis of specifically labeled nicotine molecules. Biochemische Zeitschrift 340: 326–336.Google Scholar
Doolittle, D. J., Rahn, C. A. and Lee, C. K. 1991 The effect of exposure to nicotine, carbon monoxide, cigarette smoke or cigarette smoke condensate on the mutagenicity of rat urine. Mutation Research 260: 9–18.CrossRefGoogle ScholarPubMed
Farmer, P. B. 1994 Carcinogen adducts: Use in diagnosis and risk assessment. Clinical Chemistry 40: 1438–1443.Google Scholar
Felton, J. S., Turteltaub, K. W., Vogel, J. S., Balhorn, R., Gledhill, B. L., Southon, J. R., Caffee, M. W., Finkel, R. C., Nelson, D. E., Proctor, I. D. and Davis, J. C. 1990 Accelerator mass spectrometry in the biomedical sciences: Applications in low-exposure biomedical and environmental dosimetry. Nuclear Instruments and Methods in Physics Research B52: 517–523.Google Scholar
Frantz, C. E., Bangerter, C., Fultz, E., Mayer, K. M., Vogel, J.S. and Turteltaub, K. W. 1995 Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis 16: 367–373.CrossRefGoogle ScholarPubMed
Gupta, R. C. 1984 Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proceedings of the National Academy of Sciences 81: 6943–6947.Google Scholar
Gupta, R. C. 1985 Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen; DNA adducts. Cancer Research 45: 5656–5662.Google Scholar
Hecht, S. S., Young, R. and Chen, C. B. 1980 Metabolism in the F344 rat of 4-( N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. Cancer Research 40: 4144–4150.Google Scholar
Hoffmann, D. and Hecht, S. S. 1985 Nicotine-derived N-nitrosamines and tobacco-related cancer: Current status and future directions. Cancer Research 45: 935–944.Google Scholar
Liu, Y. F., Guo, Z. Y., Liu, X. Q., Qu, T. and Xie, J. L. 1994 Applications of accelerator mass spectrometry in analysis of trace isotopes and elements. Pure and Applied Chemistry 66: 305–334.CrossRefGoogle Scholar
Margison, G. P. and O'Connor, P. J. 1979 Nucleic acids and modification by N-nitroso compounds. In Grover, P. L., ed., Chemical Carcinogens and DNA, Vol 1. Boca Raton, Florida, CRC Press: 111–159.Google Scholar
Phillips, D. H., Hewer, A., Martin, C. N., Garner, R. C. and King, N. N. 1988 Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 336: 22–29.CrossRefGoogle ScholarPubMed
Turteltaub, K. W., Vogel, J. S., Frantz, C. E. and Shen, N. 1992 Fate and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-6]pyridine in mice at a human dietary equivalent dose. Cancer Research 52: 4682–4687.Google Scholar
Vogel, J. S. 1992 Rapid production of graphite without contamination for biomedical AMS. Radiocarbon 34: 344–350.Google Scholar
Vogel, J. S. and Turteltaub, K. W. 1992 Biomolecular tracing through accelerator mass spectrometry. Trends in Analytical Chemistry 11: 142–149.Google Scholar
Weisman, J. 1996 AMS adds realism to chemical risk assessment. Science 271: 286–287.Google Scholar